Depreciation, Depletion and Amortization of Allogene Therapeutics, Inc. from 31 Dec 2018 to 31 Dec 2025

Taxonomy & unit
us-gaap: USD
Description
The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.
Summary
Allogene Therapeutics, Inc. annual and quarterly Depreciation, Depletion and Amortization in USD history and change rate from 31 Dec 2018 to 31 Dec 2025.
  • Allogene Therapeutics, Inc. Depreciation, Depletion and Amortization for the quarter ending 31 Mar 2025 was $3,099,000, a 13% decline year-over-year.
  • Allogene Therapeutics, Inc. annual Depreciation, Depletion and Amortization for 2025 was $12,359,000, a 9.4% decline from 2024.
  • Allogene Therapeutics, Inc. annual Depreciation, Depletion and Amortization for 2024 was $13,639,000, a 3.9% decline from 2023.
  • Allogene Therapeutics, Inc. annual Depreciation, Depletion and Amortization for 2023 was $14,199,000, a 0.71% decline from 2022.
Source SEC data
View on sec.gov
Depreciation, Depletion and Amortization, Annual (USD)
Depreciation, Depletion and Amortization, YoY Annual Change (%)
Depreciation, Depletion and Amortization, Quarterly (USD)
Depreciation, Depletion and Amortization, YoY Quarterly Change (%)

Allogene Therapeutics, Inc. Annual Depreciation, Depletion and Amortization (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2025 $12,359,000 -$1,280,000 -9.4% 01 Jan 2025 31 Dec 2025 10-K 12 Mar 2026 2025 FY
2024 $13,639,000 -$560,000 -3.9% 01 Jan 2024 31 Dec 2024 10-K 12 Mar 2026 2025 FY
2023 $14,199,000 -$101,000 -0.71% 01 Jan 2023 31 Dec 2023 10-K 13 Mar 2025 2024 FY
2022 $14,300,000 +$3,800,000 +36% 01 Jan 2022 31 Dec 2022 10-K 14 Mar 2024 2023 FY
2021 $10,500,000 +$3,100,000 +42% 01 Jan 2021 31 Dec 2021 10-K 14 Mar 2024 2023 FY
2020 $7,400,000 +$2,800,000 +61% 01 Jan 2020 31 Dec 2020 10-K/A 14 Mar 2024 2022 FY
2019 $4,600,000 +$3,600,000 +360% 01 Jan 2019 31 Dec 2019 10-K 23 Feb 2022 2021 FY
2018 $1,000,000 01 Jan 2018 31 Dec 2018 10-K 25 Feb 2021 2020 FY

Allogene Therapeutics, Inc. Quarterly Depreciation, Depletion and Amortization (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q1 2025 $3,099,000 -$456,000 -13% 01 Jan 2025 31 Mar 2025 10-Q 13 May 2025 2025 Q1
Q1 2024 $3,555,000 01 Jan 2024 31 Mar 2024 10-Q 13 May 2025 2025 Q1
* An asterisk sign (*) next to the value indicates that the value is likely invalid.